PATENT CLAIM ANALYSIS

Application Number: 15760210
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "291000"]

Abstract:
For preventing or treating keratomycosis, a medicament containing rapamycin or a salt thereof as an active ingredient is used.

Claim (Index 8):
The method according to  claim 7 , wherein the subconjunctival administration is by injection.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 90.0
- Lexical Diversity: 1.10526
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12193686', '15660470', '15558893', '13741103', '14151647']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7704247476924347
- 35 USC 102 Novelty (BERT): 0.4894410525167657
- Combined Prediction Score: 0.7423263781748679
- Mean Citation Score: 182.341564
- Max Citation Score: 206.80174
- Similarity Product: 149.98818948829177

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test